Revenues: | |
Research and development support | 1.35M |
License and milestone fees | 76K |
Clinical materials reimbursement | 46K |
Total revenues | 7.66M |
Operating Expenses: | |
Research and development | 32.91M |
General and administrative | 9.46M |
Total operating expenses | 46.5M |
Loss from operations | -38.84M |
Other (expense) income, net | 129K |
Loss before provision for income taxes | |
Net loss | -44.73M |
Basic and diluted net loss per common share (in dollars per share) | -0.51 |
Basic weighted average common shares outstanding (in shares) | |
Diluted weighted average common shares outstanding (in shares) |